REGISTERED NUMBER: SC730057 (Scotland)

Unaudited Financial Statements for the Year Ended 30 April 2026

for

Oralcare Direct Limited

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTOR:

J Moore

REGISTERED OFFICE:

44 Speirs Wharf

Unit 2a

Glasgow

G4 9TH

REGISTERED NUMBER:

SC730057 (Scotland)

ACCOUNTANTS:

Greg Hannah Ltd

Chartered Accountants

29 Brandon Street

Hamilton

ML3 6DA

FIXED ASSETS

Tangible assets

5

22,549

25,136

CURRENT ASSETS

Stocks

21,294

24,438

Debtors

6

218,951

183,864

Cash at bank

60,011

56,943

300,256

265,245

CREDITORS

Amounts falling due within one year

7

159,207

161,273

NET CURRENT ASSETS

141,049

103,972

TOTAL ASSETS LESS CURRENT LIABILITIES

163,598

129,108

CREDITORS

Amounts falling due after more than one year

8

(74,299

)

(45,500

)

PROVISIONS FOR LIABILITIES

(5,637

)

(4,702

)

NET ASSETS

83,662

78,906

CAPITAL AND RESERVES

Called up share capital

1

1

Retained earnings

83,661

78,905

83,662

78,906

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 April 2026.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 April 2026 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 4 September 2026 and were signed by:

J Moore - Director

1.	STATUTORY INFORMATION

Oralcare Direct Limited is a private company, limited by shares , registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).

2.	STATEMENT OF COMPLIANCE

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. There were no material departures from that standard.

3.	ACCOUNTING POLICIES

Basis of preparing the financial statements

The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is derived from dental products manufactured by the company

Turnover is measured at the fair value of the product supplied, net of discounts and excluding value added tax, and is recognised at the point that the company obtains the right to consideration.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and machinery etc

-

25% on cost

Tangible fixed assets held for the companies own use are stated at cost less accumulated depreciation and accumulated impairment loss.

At each balance sheet date, the company reviews the carrying amounts of its tangible fixed assets to determine whether there is any indication that any items have suffered an impairment loss. If any such indication exists, the recoverable amount of an asset is estimated in order to determine the extent of the impairment loss. Where it is not possible to estimate the recoverable amount of the asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Expenditure of £500 or more on individual tangible fixed assets is capitalised at cost. Expenditure on assets below this threshold is charged directly to the profit and loss account in the period it is incurred.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell (net realisable value). Costs, which comprise direct production costs, are based on the method appropriate to the type of inventory class, but usually on a first-in-first-out basis. Overheads are charged to the income statement as incurred. Net realisable value is based on the estimated selling price less any estimated completion or selling costs.

When stocks are sold, the carrying amount of those stocks is recognised as an expense in the period in which the related revenue is recognised. The amount of any write-down of stocks to net realisable value and all losses of stocks are recognised as an expense in the period in which the write-down or loss occurs. The amount of any reversal of any write-down of stocks is recognised as a reduction in the amounts of stocks recognised as an expense in the period in which the reversal occurs.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

4.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 7 (2025 - 8 ) .

5.	TANGIBLE FIXED ASSETS

Plant and

machinery

etc

£

COST

At 1 May 2025

33,620

Additions

7,862

At 30 April 2026

41,482

DEPRECIATION

At 1 May 2025

8,484

Charge for year

10,449

At 30 April 2026

18,933

NET BOOK VALUE

At 30 April 2026

22,549

At 30 April 2025

25,136

6.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2026

2025

£

£

Trade debtors

169,454

120,230

Other debtors

49,497

63,634

218,951

183,864

7.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2026

2025

£

£

Bank loans and overdrafts

19,405

14,000

Trade creditors

41,050

33,176

Taxation and social security

82,810

33,564

Other creditors

15,942

80,533

159,207

161,273

8.

CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

2026

2025

£

£

Bank loans

74,299

45,500

9.	SECURED DEBTS

The following secured debts are included within creditors:

2026

2025

£

£

Invoice financing

-

47,750

Bank loan

48,203

-

48,203

47,750

The company has entered into an invoice finance facility with RBS Invoice Finance Limited. The facility is secured by a floating charge over the assets of the company.

The company's bank borrowing is supported by a personal guarantee provided by John Moore.

10.	RELATED PARTY DISCLOSURES

J Moore

Director

During the year, the company was advanced £1,116 by the director. The balance due to the director at the year end was £1,568 (2025: £452)). There were no fixed repayment terms and no interest was charged.

Wallthom Whitebox Orthodontic Laboratory Limited

A company in which J Moore is a director and Oralcare Direct Limited has a controlling interest.

At the year end, the balance due from Wallthom Whitebox Orthodontic Laboratory Limited was £16,887 (2025 - £44,612). There were no fixed repayment terms and no interest was charged.

During the year, Oralcare Direct Ltd purchased goods for a total of £7,824. These transactions took place at market value.